ZA974779B - Thrombin inhibitors. - Google Patents

Thrombin inhibitors.

Info

Publication number
ZA974779B
ZA974779B ZA9704779A ZA974779A ZA974779B ZA 974779 B ZA974779 B ZA 974779B ZA 9704779 A ZA9704779 A ZA 9704779A ZA 974779 A ZA974779 A ZA 974779A ZA 974779 B ZA974779 B ZA 974779B
Authority
ZA
South Africa
Prior art keywords
thrombin inhibitors
thrombin
inhibitors
Prior art date
Application number
ZA9704779A
Other languages
English (en)
Inventor
Derek Edward Brundish
Lyndon Nigel Brown
Darren Mark Le Grand
Keith Allan Menear
Garrick Paul Smith
Mark Christopher Allen Butler
Xiao-Ling Cockroft
Ian Timothy William Matthews
Clive Victor Walker
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA974779B publication Critical patent/ZA974779B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9704779A 1996-06-01 1997-05-30 Thrombin inhibitors. ZA974779B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9611461.6A GB9611461D0 (en) 1996-06-01 1996-06-01 New compounds

Publications (1)

Publication Number Publication Date
ZA974779B true ZA974779B (en) 1997-12-01

Family

ID=10794610

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704779A ZA974779B (en) 1996-06-01 1997-05-30 Thrombin inhibitors.

Country Status (8)

Country Link
AR (1) AR008376A1 (fr)
AU (1) AU2908197A (fr)
CO (1) CO4940504A1 (fr)
GB (1) GB9611461D0 (fr)
ID (1) ID16990A (fr)
PE (1) PE69498A1 (fr)
WO (1) WO1997046553A1 (fr)
ZA (1) ZA974779B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112679448A (zh) * 2020-12-31 2021-04-20 苏州昊帆生物股份有限公司 N-（2-氨基乙基）吗啉的制备方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1401821A4 (fr) * 2001-06-12 2006-05-31 Sk Corp Nouveaux analogues de phenylalkyl diamine et d'amide
AU2002331064B2 (en) * 2001-08-10 2007-08-23 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
EP2294051B1 (fr) * 2008-05-22 2014-08-13 Boehringer Ingelheim International GmbH N-sulfonylglycinamides alpha-substitués antagonistes du ccr10, compositions les contenant, et leurs procédés d'utilisation
WO2012068106A2 (fr) 2010-11-15 2012-05-24 Exelixis, Inc. Benxazépines en tant qu'inhibiteurs de pi3k/mtor et leurs procédés d'utilisation et de fabrication
EP2643316A2 (fr) 2010-11-24 2013-10-02 Exelixis, Inc. Benzoxazépines utilisées comme inhibiteurs de p13k/mtor et procédés d'utilisation et de fabrication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31294A (en) * 1992-02-13 1998-07-06 Thomae Gmbh Dr K Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and process for preparing them.
CA2150550A1 (fr) * 1992-12-01 1994-06-09 Melissa S. Egbertson Antagonistes du recepteur du fibrinogene
FR2727413B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Derives de 5-(1h-imidazol-4-yl)-1-oxo-2-(phenylsulfonamino)- pentylpiperidine, leur preparation et leur application en therapeutique

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112679448A (zh) * 2020-12-31 2021-04-20 苏州昊帆生物股份有限公司 N-（2-氨基乙基）吗啉的制备方法

Also Published As

Publication number Publication date
PE69498A1 (es) 1998-11-27
ID16990A (id) 1997-11-27
WO1997046553A1 (fr) 1997-12-11
AU2908197A (en) 1998-01-05
AR008376A1 (es) 2000-01-19
CO4940504A1 (es) 2000-07-24
GB9611461D0 (en) 1996-08-07

Similar Documents

Publication Publication Date Title
EP0927035A4 (fr) Inhibiteurs de thrombine
EP0969840A4 (fr) Inhibiteurs de thrombine
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
IL128663A0 (en) 1,4-heterocyclic metalloprotease inhibitors
IL128661A0 (en) 1,3-diheterocyclic metalloprotease inhibitors
EP1124822A4 (fr) Inhibiteurs de la thrombine
EP0971891A4 (fr) Inhibiteurs de thrombine
HUP0001826A3 (en) Thrombin inhibitors
PL328307A1 (en) Serinic protease inhibitors
PL328875A1 (en) Serinic protease inhibitors
PL331803A1 (en) Bidonoric metaloprotease inhibitors
PL328223A1 (en) Aspartil protease inhibitors
EP1117660A4 (fr) Inhibiteurs de la thrombine
IL136139A0 (en) Thrombin inhibitors
AU3396697A (en) Thrombin inhibitor
GB9613718D0 (en) Thrombin inhibitors
ZA977209B (en) Thrombin inhibitors.
ZA974779B (en) Thrombin inhibitors.
EP1017383A4 (fr) Inhibiteurs de thrombine
EP1039907A4 (fr) Inhibiteurs de thrombine
EP1027333A4 (fr) Inhibiteurs de thrombine
ZA968968B (en) Selective thrombin inhibitors.
GB9625311D0 (en) Thrombin inhibitors
GB9624278D0 (en) Thrombin inhibitors
GB9624292D0 (en) Thrombin inhibitors